Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update

Go back to Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update
(NASDAQ: TSHA) Delayed: 5.06 -0.1 (1.94%)
Previous Close $5.16    52 Week High
Open $5.16    52 Week Low
Day High $5.28    P/E N/A 
Day Low $5.01    EPS
Volume 2,003,740